Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Exact Sciences Corp.
Headquarters: Madison, WI, United States of America
Website: http://www.exactsciences.com...
Year Founded: 1995
Status: Public
Industry Sector: HealthTechnology
CEO: Kevin T. Conroy
Number Of Employees: 7,000
Enterprise Value: $12,087,761,430
PE Ratio: -7.85
Exchange/Ticker 1: NASDAQ:EXAS
Exchange/Ticker 2: N/A
Latest Market Cap: $8,111,921,152
BioCentury | Mar 18, 2025
Management Tracks
Zenas names Lisa von Moltke head of R&D and CMO
Plus: CBC’s Lan Kang becomes CEO of Azkarra, and updates from Ionctura, Sunbird and Surf Bio
BioCentury | Feb 7, 2025
Discovery & Translation
Science Spotlight: Ranking AAV capsids for liver gene therapy
BioCentury’s roundup of translational innovation also includes high-resolution spatial proteomics, a more diverse microbiome atlas, and more
BioCentury | Jun 4, 2024
Management Tracks
New commercial heads for Illumina, UroGen, Invivyd
Plus: Jennifer Fitzpatrick hired as general counsel at Sionna
BioCentury | Apr 16, 2024
Management Tracks
Viatris hires Corinne Le Goff as commercial head
Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | Oct 2, 2023
Management Tracks
GSK vet Lepore named CEO of Flagship’s ProFound
Plus: CEO Simonian retiring as Syros reorganizes, and updates from Broken String, Repligen, AmbioPharm, BPGbio and LifeArc
BioCentury | Aug 25, 2023
Product Development
Grail partnership latest step for broader access to multicancer tests
Study to evaluate community outreach strategies for increasing early cancer screening in diverse populations, follows similar deal by Exact Sciences in June
BioCentury | Jun 12, 2023
Product Development
Multicancer early detection tests: the view from ASCO23
Prospective studies provide reassuring signals of safety, but identifying the right target populations remains a challenge for proving clinical utility
BioCentury | Mar 30, 2023
Politics, Policy & Law
Federal judge’s ruling could reduce access to cancer screening, HIV prevention drugs
Appeal of Texas judge’s ruling on ACA expected
BioCentury | Jan 13, 2023
Finance
4Q22 Wrap: Stopping the bleeding
Winners, losers across biotech market cap tiers in 4Q22
BioCentury | Dec 20, 2022
Management Tracks
MorphoSys’ CFO Lee leaving
Plus: Mestag names Logtenberg as chair and updates from Edgewise, Myriad and Venatorx
Items per page:
1 - 10 of 237